Primary CNS Lymphoma

Study of Lenalidomide/Rituximab Maintenance for Transplantation Ineligible Patients With PCNSL.

Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study)

Tisagenlecleucel In Primary CNS Lymphoma

19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers

Diagnosis; Objective RespOnse; THErApy

Immunotherapy Using CAR T-cells to Target CD19 for Relapsed/Refractory CD19+ Primary CNS Lymphoma

Feasibility of Acquiring Hyperpolarized Imaging in Patients With Primary CNS Lymphoma

Prospective Neurobehavioral Functions in Newly-diagnosed Patients With Primary CNS Lymphoma Treated With Hyperfractionated Conformal Whole-brain Radiation Therapy Plus Simultaneous Integrated Boost

B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021

RL-MPV Followed by BBC HCT Using Autologous Stem Cells and Maintenance Therapy With Nivolumab for Newly Diagnosed PCNSL

Venetoclax and Obinutuzumab for Relapsed/Refractory Primary CNS Lymphoma

[CREMA]Combination of R-M Followed by R-A in Elderly Patients With Primary CNS Lymphoma

Study Of Durvalumab and Lenalidomide In R/R EBV Associated DLBCL Subtypes, Primary CNS And Testicular DLBCL

Temozolomide in Treatment of Patients With Primary Central Nervous System Lymphoma